Cargando…
The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain
Gabapentin has been used as an adjuvant for treatment of cancer pain. Previous studies showed that opioids combined with gabapentin for management of cancer pain reduced the dosage of opioids. The objective of this study was to explore the clinical effect and patients’ satisfaction of oxycontin comb...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079328/ https://www.ncbi.nlm.nih.gov/pubmed/27759644 http://dx.doi.org/10.1097/MD.0000000000005144 |
_version_ | 1782462545564532736 |
---|---|
author | Chen, Dong-Liang Li, Yu-Hong Wang, Zhi-Juan Zhu, Ye-Ke |
author_facet | Chen, Dong-Liang Li, Yu-Hong Wang, Zhi-Juan Zhu, Ye-Ke |
author_sort | Chen, Dong-Liang |
collection | PubMed |
description | Gabapentin has been used as an adjuvant for treatment of cancer pain. Previous studies showed that opioids combined with gabapentin for management of cancer pain reduced the dosage of opioids. The objective of this study was to explore the clinical effect and patients’ satisfaction of oxycontin combined with gabapentin in treatment of severe cancer pain. After titration of morphine, 60 severe cancer patients with visual analog score (VAS) more than 7 were randomly divided into trial group (n = 30) and control group (n = 30). The control group was administered oxycontin and placebo, and the trial group was given oxycontin and gabapentin. VAS score was recorded pre- and post-treatment; while daily dose of oxycontin, daily cost of pain relief and life quality score were observed 1 week, 1 month, 2 months, 3 months, and 6 months post-treatment. We found that daily dose of oxycontin 1 month post was comparable between the 2 groups (P > 0.05). Three months post, compared with control group (58.0 ± 15.2 mg), average daily dose of oxycontin was significant lower in trial group (33.4 ± 11 mg) (P < 0.001). Average daily cost of pain relief in trail group (34.5 ± 10.2 RMB) was less than the control group (52.4 ± 13.7 RMB) (P < 0.001). Life quality score increased in all of the patients in both group post-treatment (P < 0.05); while life quality score in trail group was greater than in control group 3 months (46.8 ± 4.5 vs 43.5 ± 4.6, P = 0.007) and 6 months (46.5 ± 4.8 vs 41.4 ± 4.3, P < 0.001) post-treatment. The incidence of drowsiness and dizziness was comparable between the 2 groups (P > 0.05), while the incidence of nausea and vomiting (P = 0.038), and constipation (P < 0.001) was higher in the control group. We concluded that oxycontin combined with gabapentin used in severe cancer pain management can control pain effectively, decreased the dose of oxycontin and the cost of cancer pain relief, and reduced the incidence of nausea and vomiting, and constipation, increased the life quality. |
format | Online Article Text |
id | pubmed-5079328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-50793282016-11-03 The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain Chen, Dong-Liang Li, Yu-Hong Wang, Zhi-Juan Zhu, Ye-Ke Medicine (Baltimore) 3300 Gabapentin has been used as an adjuvant for treatment of cancer pain. Previous studies showed that opioids combined with gabapentin for management of cancer pain reduced the dosage of opioids. The objective of this study was to explore the clinical effect and patients’ satisfaction of oxycontin combined with gabapentin in treatment of severe cancer pain. After titration of morphine, 60 severe cancer patients with visual analog score (VAS) more than 7 were randomly divided into trial group (n = 30) and control group (n = 30). The control group was administered oxycontin and placebo, and the trial group was given oxycontin and gabapentin. VAS score was recorded pre- and post-treatment; while daily dose of oxycontin, daily cost of pain relief and life quality score were observed 1 week, 1 month, 2 months, 3 months, and 6 months post-treatment. We found that daily dose of oxycontin 1 month post was comparable between the 2 groups (P > 0.05). Three months post, compared with control group (58.0 ± 15.2 mg), average daily dose of oxycontin was significant lower in trial group (33.4 ± 11 mg) (P < 0.001). Average daily cost of pain relief in trail group (34.5 ± 10.2 RMB) was less than the control group (52.4 ± 13.7 RMB) (P < 0.001). Life quality score increased in all of the patients in both group post-treatment (P < 0.05); while life quality score in trail group was greater than in control group 3 months (46.8 ± 4.5 vs 43.5 ± 4.6, P = 0.007) and 6 months (46.5 ± 4.8 vs 41.4 ± 4.3, P < 0.001) post-treatment. The incidence of drowsiness and dizziness was comparable between the 2 groups (P > 0.05), while the incidence of nausea and vomiting (P = 0.038), and constipation (P < 0.001) was higher in the control group. We concluded that oxycontin combined with gabapentin used in severe cancer pain management can control pain effectively, decreased the dose of oxycontin and the cost of cancer pain relief, and reduced the incidence of nausea and vomiting, and constipation, increased the life quality. Wolters Kluwer Health 2016-10-21 /pmc/articles/PMC5079328/ /pubmed/27759644 http://dx.doi.org/10.1097/MD.0000000000005144 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0, where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 3300 Chen, Dong-Liang Li, Yu-Hong Wang, Zhi-Juan Zhu, Ye-Ke The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
title | The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
title_full | The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
title_fullStr | The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
title_full_unstemmed | The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
title_short | The research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
title_sort | research on long-term clinical effects and patients’ satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079328/ https://www.ncbi.nlm.nih.gov/pubmed/27759644 http://dx.doi.org/10.1097/MD.0000000000005144 |
work_keys_str_mv | AT chendongliang theresearchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT liyuhong theresearchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT wangzhijuan theresearchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT zhuyeke theresearchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT chendongliang researchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT liyuhong researchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT wangzhijuan researchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain AT zhuyeke researchonlongtermclinicaleffectsandpatientssatisfactionofgabapentincombinedwithoxycontinintreatmentofseverecancerpain |